New sedative shows promise for Long-Term ICU sedation
NCT ID NCT05913336
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tested a drug called remimazolam tosilate to keep ICU patients calm and comfortable while they are on a breathing machine for three days or more. Researchers wanted to see if the drug works well and is safe. The trial included 24 adults aged 18 to 80 with a healthy weight. The goal was to maintain the right level of sedation without needing extra calming drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEDATION IN THE ICU are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550001, China
Conditions
Explore the condition pages connected to this study.